Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20201
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting2
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
GlaxoSmithKline2
Astellas Pharma Inc1
Iwate Medical University1
Novartis Pharmaceuticals1
Tanabe Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms10
Breast Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Ovarian Neoplasms2
Stomach Neoplasms2
Uterine Cervical Neoplasms2
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.